{
    "nct_id": "NCT04914663",
    "official_title": "All-extremity Exercise as a Novel Strategy for Optimizing Cardiovascular Function During Chemotherapy for Breast Cancer",
    "inclusion_criteria": "* Active diagnosis of primary invasive non-metastatic breast cancer, stages I-III\n* Female\n* 18 to 85 years of age\n* Scheduled to initiate neoadjuvant or adjuvant chemotherapy (anthracycline, alkylating agent and/or taxane)\n* Absence of contraindications to exercise\n* Study clinician approval\n* Able to give consent\n* Informed consent obtained from the subject and documentation of subject agreement to comply with study-related process\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 85 Years",
    "exclusion_criteria": "* Do not meet inclusion criteria\n* Receiving targeted therapies (CDK4/6 or PARP inhibitors)\n* Receiving radiation therapy concurrent with chemotherapy\n* Lymphedema stage â‰¥ 2 prior to study enrollment\n* Any relevant cardiovascular diseases (stroke, heart failure, myocardial ischemia during maximal graded exercise test, myocardial infarction, angina pectoris, coronary artery bypass surgery or angioplasty or coronary stent)\n* Current participation in other experimental interventions that may confound interpretation of study findings (e.g., dietary intervention for weight loss)",
    "miscellaneous_criteria": ""
}